Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE HealthCare
GEHC
|
+$484M |
| 2 |
Microsoft
MSFT
|
+$417M |
| 3 |
Amazon
AMZN
|
+$365M |
| 4 |
Apple
AAPL
|
+$357M |
| 5 |
Merck
MRK
|
+$311M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Aerospace
GE
|
+$420M |
| 2 |
SIVB
SVB Financial Group
SIVB
|
+$288M |
| 3 |
Philip Morris
PM
|
+$246M |
| 4 |
Canadian Pacific Kansas City
CP
|
+$228M |
| 5 |
Meta Platforms (Facebook)
META
|
+$208M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.14% |
| 2 | Healthcare | 13.96% |
| 3 | Financials | 12.57% |
| 4 | Consumer Discretionary | 10.55% |
| 5 | Industrials | 9.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1626
Liberty Global Class A
LBTYA
$3.6B
| $26.1M | ﹤0.01% |
1,340,240
+145,750
| +12% | +$2.96M |
|
1627
Arvinas
ARVN
$572M
| $26.1M | ﹤0.01% |
955,801
+41,507
| +5% | +$1.31M |
|
|
AVNS
1628
DELISTED
Avanos Medical
AVNS
| $26.1M | ﹤0.01% |
877,740
+31,152
| +4% | +$904K |
|
1629
Payoneer
PAYO
$2.4B
| $25.9M | ﹤0.01% |
4,128,795
+156,861
| +4% | +$933K |
|
1630
Syndax Pharmaceuticals
SNDX
$1.82B
| $25.9M | ﹤0.01% |
1,227,601
+126,572
| +11% | +$3.15M |
|
1631
Q2 Holdings
QTWO
$3.92B
| $25.9M | ﹤0.01% |
1,052,433
+47,699
| +5% | +$1.42M |
|
1632
Abercrombie & Fitch
ANF
$5B
| $25.9M | ﹤0.01% |
931,938
+28,062
| +3% | +$781K |
|
1633
Triumph Financial Inc
TFIN
$1.82B
| $25.9M | ﹤0.01% |
445,241
+12,801
| +3% | +$734K |
|
1634
ePlus
PLUS
$2.34B
| $25.8M | ﹤0.01% |
526,701
+24,112
| +5% | +$1.22M |
|
1635
Virtu Financial
VIRT
$4.93B
| $25.8M | ﹤0.01% |
1,364,456
+26,211
| +2% | +$504K |
|
1636
Under Armour
UAA
$2.6B
| $25.7M | ﹤0.01% |
2,706,243
+88,367
| +3% | +$918K |
|
1637
Freshworks
FRSH
$3.27B
| $25.6M | ﹤0.01% |
1,669,727
+44,107
| +3% | +$668K |
|
|
VISN
1638
Vistance Networks Inc
VISN
$2.52B
| $25.6M | ﹤0.01% |
4,025,534
+179,410
| +5% | +$1.36M |
|
|
HBI
1639
DELISTED
Hanesbrands
HBI
| $25.6M | ﹤0.01% |
4,868,060
+142,472
| +3% | +$896K |
|
1640
Primoris Services
PRIM
$4.45B
| $25.5M | ﹤0.01% |
1,034,668
+35,626
| +4% | +$900K |
|
|
AKRO
1641
DELISTED
Akero Therapeutics
AKRO
| $25.5M | ﹤0.01% |
665,927
+32,547
| +5% | +$1.45M |
|
1642
New Fortress Energy
NFE
$101M
| $25.5M | ﹤0.01% |
865,056
+35,932
| +4% | +$1.27M |
|
1643
Leslie's
LESL
$11M
| $25.4M | ﹤0.01% |
115,568
+7,731
| +7% | +$2.01M |
|
1644
Scorpio Tankers
STNG
$3.81B
| $25.4M | ﹤0.01% |
450,235
+25,655
| +6% | +$1.4M |
|
1645
Liberty Latin America Class C
LILAK
$1.64B
| $25.3M | ﹤0.01% |
3,374,521
+107,070
| +3% | +$852K |
|
|
VRE
1646
DELISTED
Veris Residential
VRE
| $25.3M | ﹤0.01% |
1,725,472
+47,367
| +3% | +$755K |
|
|
JWN
1647
DELISTED
Nordstrom
JWN
| $25.2M | ﹤0.01% |
1,549,612
+52,596
| +4% | +$983K |
|
|
JBGS
1648
JBG SMITH
JBGS
$708M
| $25.1M | ﹤0.01% |
1,666,507
+42,968
| +3% | +$762K |
|
1649
Agios Pharmaceuticals
AGIO
$1.93B
| $25M | ﹤0.01% |
1,089,359
+33,801
| +3% | +$898K |
|
|
CIM
1650
Chimera Investment
CIM
$1B
| $25M | ﹤0.01% |
1,475,666
+39,654
| +3% | +$759K |
|
Similar funds
Geode Capital Management's Q1 2023 Portfolio in Review
As of Q1 2023, Geode Capital Management held 4,968 positions worth $770B, up 8.1% from $713B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Trading was light in Q1 2023: portfolio turnover was 4.6%. Geode Capital Management opened 69 new positions and exited 162, leaving the 4,968-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
- Geode Capital Management's largest Q1 2023 buy was GE HealthCare: 6,775,612 shares worth $554M.
- Geode Capital Management added most to Microsoft in Q1 2023, an estimated $417M increase.
- Geode Capital Management's biggest Q1 2023 reduction was GE Aerospace, cutting an estimated $420M.
- Geode Capital Management fully exited SVB Financial Group in Q1 2023, selling an estimated $288M.
- Geode Capital Management's ten largest holdings make up 23% of its $770B portfolio in Q1 2023.
- Geode Capital Management opened 69 new positions and closed 162 in Q1 2023.
- Geode Capital Management's portfolio value rose 8.1% quarter-over-quarter to $770B.
Based on Geode Capital Management's 13F filing for Q1 2023, filed 15 May 2023.